tiprankstipranks
Invesque Inc (TSE:IVQ)
TSX:IVQ
Want to see TSE:IVQ full AI Analyst Report?

Invesque (IVQ) AI Stock Analysis

10 Followers

Top Page

TSE:IVQ

Invesque

(TSX:IVQ)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - Gpt-5.6Sol)
Rating:42Neutral
Price Target:
C$0.09
▼(-9.00% Downside)
Action:Reiterated
Date:08/17/26
The score is held down primarily by weak financial performance (sharp TTM revenue decline, ongoing losses, and negative operating/free cash flow). Technicals add additional pressure with the price below key moving averages and negative MACD, despite an oversold stochastic. Valuation provides limited support because the negative P/E reflects unprofitable operations and no dividend yield data is available.
Positive Factors
Lower Leverage
The substantial reduction in leverage improves financial flexibility and lowers balance-sheet risk. It may give Invesque greater capacity to manage maturities, withstand operating volatility, and pursue asset or financing actions over the next several months.
Negative Factors
Severe Revenue Contraction
A multi-year revenue decline, capped by a severe TTM step-down, indicates shrinking operating scale and weaker asset or tenant contribution. Sustained contraction can reduce fixed-cost absorption, impair reinvestment capacity, and pressure future cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Lower Leverage
The substantial reduction in leverage improves financial flexibility and lowers balance-sheet risk. It may give Invesque greater capacity to manage maturities, withstand operating volatility, and pursue asset or financing actions over the next several months.
Read all positive factors

Invesque (IVQ) vs. iShares MSCI Canada ETF (EWC)

Invesque Business Overview & Revenue Model

Company Description
Invesque Inc. functions as a real estate investment trust primarily focused on the healthcare sector. The company's diverse portfolio encompasses properties dedicated to independent living, assisted living, memory care, skilled nursing, and transi...
How the Company Makes Money
Invesque makes money primarily by owning healthcare-related real estate and generating cash flow from those assets. Key revenue streams typically include (1) rental and lease income from properties leased to operators/tenants under contractual lea...

Invesque Financial Statement Overview

Summary
Financial performance is weak overall: the income statement shows multi-year revenue contraction and a severe TTM revenue step-down (~-72.9%) with deeply negative operating and net results. Cash flow has also turned negative in 2025 and remains negative in TTM, indicating the business is not currently self-funding. The main offset is a much improved balance sheet with materially lower leverage in 2025/TTM, reducing near-term financial risk.
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
24
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.27M79.44M162.67M188.75M198.03M210.45M
Gross Profit4.28M27.79M59.00M72.41M95.59M90.97M
EBITDA-32.11M-9.72M24.27M-18.83M10.38M49.13M
Net Income-38.59M-31.49M-36.14M-99.24M-42.01M-28.54M
Balance Sheet
Total Assets105.78M130.80M637.22M828.28M1.10B1.30B
Cash, Cash Equivalents and Short-Term Investments10.19M39.26M18.16M10.74M27.58M19.37M
Total Debt6.12M33.52M394.84M588.25M765.46M893.75M
Total Liabilities11.69M36.69M518.05M681.18M865.69M1.01B
Stockholders Equity94.09M94.11M119.17M146.59M231.65M286.26M
Cash Flow
Free Cash Flow-3.24M-14.26M4.40M217.00K5.40M11.11M
Operating Cash Flow-2.66M-11.66M9.27M6.03M11.91M18.68M
Investing Cash Flow141.23M397.12M152.21M132.05M137.49M119.19M
Financing Cash Flow-138.21M-363.91M-154.07M-154.92M-141.19M-152.63M

Invesque Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.10
Price Trends
50DMA
0.12
Negative
100DMA
0.12
Negative
200DMA
0.13
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
47.57
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.12, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.57 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:IVQ.

Invesque Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
C$1.52B8.879.49%0.17%5.14%-43.08%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
65
Neutral
C$45.37M8.843.54%2.08%-0.76%-20.95%
61
Neutral
C$1.54B-101.94-16.05%0.28%10.21%50.83%
60
Neutral
C$112.30M8.178.51%-15.23%0.74%
46
Neutral
C$28.55M12.60-2.50%42.86%-6.17%
42
Neutral
C$91.56M-1.90-40.58%23.12%-92.36%80.14%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IVQ
Invesque
0.11
-0.02
-12.00%
TSE:IEI
Imperial Equities
4.80
1.02
27.05%
TSE:MEQ
Mainstreet Equity
166.85
-23.86
-12.51%
TSE:SVI
Storagevault Canada
4.21
-0.52
-10.94%
TSE:PKT
Parkit Enterprise
8.01
-0.54
-6.32%
TSE:BRE
Bridgemarq Real Estate Services
3.15
-10.74
-77.32%

Invesque Corporate Events

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Invesque Sheds Seniors Housing Assets Amid Sharp Revenue Drop
Negative
Aug 12, 2026
Invesque Inc., a North American health care real estate company specializing in assisted living, memory care communities and owner-occupied seniors housing, operates through joint ventures with leading operators and direct ownership of seniors hou...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 17, 2026